81099-75-4

Upstream product

• 81076-81-5 1,6-anhydro-3-O-benzyl-2,4-dideoxy-2-C-methyl-4-methylene-β-D-xylohexopyranose 
• 97321-52-3 C₁₅H₁₈O₄ 
• 91510-64-4 4-O-allyl-1,6-anhydro-2-deoxy-2-C-methyl-β-D-glucopyranose 
• 81076-77-9 1,6-anhydro-2-desoxy-2,4-di-C-methyl-3-O-benzyl-β-D-galactopyranose 
• 100-39-0 benzyl bromide 
• 91510-63-3 4-O-Allyl-1,6:2,3-dianhydro-β-D-mannopyranose 
• 76706-48-4 1,6-anhydro-2-desoxy-2,4-di-C-methyl-β-D-galactopyranose 
• 100-44-7 benzyl chloride 
• 129269-48-3 Toluene-4-sulfonic acid (1R,2S,3R,4R,5R)-3-benzyloxy-2-hydroxy-4-methyl-6,8-dioxa-bicyclo[3.2.1]oct-2-ylmethyl ester 
• 129269-47-2 (1R,2S,3R,4R,5R)-3-Benzyloxy-2-hydroxymethyl-4-methyl-6,8-dioxa-bicyclo[3.2.1]octan-2-ol 
• 498-07-7 levoglucosan 
• 129269-48-3 Toluene-4-sulfonic acid (1R,3R,4R,5R)-3-benzyloxy-2-hydroxy-4-methyl-6,8-dioxa-bicyclo[3.2.1]oct-2-ylmethyl ester 
• 129269-47-2 (1R,3R,4R,5R)-3-Benzyloxy-2-hydroxymethyl-4-methyl-6,8-dioxa-bicyclo[3.2.1]octan-2-ol 
• 81076-80-4 1,6-anhydro-2-desoxy-2,4-di-C-methyl-3-O-benzyl-4-O-mesyl-β-D-galactopyranose 

Downstream Products

• 101068-93-3 methyl-2-desoxy-2,4-di-C-methyl-3-O-benzyl-α-D-glucopyranoside 
• 81076-83-7 1,6-anhydro-2-desoxy-2,4-di-C-methyl-3,4-di-O-benzyl-β-D-glucopyranose 
• 81099-74-3 methyl-2,6,7-tridesoxy-2,4-di-C-methyl-3,4-di-O-benzyl-α-D-glucoheptapyranoside 
• 85317-33-5 methyl 2-desoxy-2,4-di-C-methyl-3,4-di-O-benzyl-α,β-D-glucopyranoside 
• 81076-84-8 methyl-2-desoxy-2,4-di-C-methyl-3,4-di-O-benzyl-β-D-glucopyranoside 
• 81099-73-2 methyl-2-desoxy-2,4-di-C-methyl-3,4-di-O-benzyl-α-D-glucopyranoside 
• 85271-59-6 methyl-2,6,7-tridesoxy-2,4-di-C-methyl-3,4-di-O-benzyl-α-D-glucohept-6-enopyranoside 
• 81076-85-9 methyl-2-desoxy-2,4-di-C-methyl-3,4-di-O-benzyl-6-aldo-α-D-glucopyranoside 

Relevant academic research and scientific papers

SYNTHESIS OF MACROLIDE ANTIBIOTICS. 19. SYNTHESIS OF THE C7-C13 FRAGMENT OF ERYTHRONOLIDE A

A stereocontrolled synthesis was carried out for the C7-C13 fragment of erythronolide A in 33 steps with an overall yield of 13percent relative to starting levoglucosan.

STEREO-CONTROLLED SYNTHESIS OF ERYTHRONOLIDES A AND B FROM 1,6-ANHYDRO-β-D-GLUCOPYRANOSE (LEVOGLUCOSAN). SKELETON ASSEMBLY IN (C9 - C13) + (C7 - C8) + (C1 - C6) SEQUENCE

Stereospecific syntheses of erythronolides A and B have been accomplished starting from 1,6-anhydro-β-D-glucopyranose (levoglucosan) in a uniform synthetic sequence.

1,6-ANHYDRO-3-O-BENZYL-2-DEOXY-2,4-DI-C-METHYL-β-D-HEXOPYRANOSES: SYNTHESIS AND PROPERTIES

The synthesis of the isomeric 1,6-anhydro-3-O-benzyl-2-deoxy-2,4-di-C-methyl-β-D-hexopyranoses and their spectral characterisation are described. 1,6-Anhydro-3-O-benzyl-2-deoxy-4-O-mesyl-2,4-di-C-methyl-β-D-galactopyranose undergoes ring-contraction on so

SYNTHESIS OF MACROLIDE ANTIBIOTICS. 2. SYNTHESIS OF THE C9-C13 SEGMENTS OF ERYTHRONOLIDES A, B AND OLEANDONOLIDE

The C9-C13 segments of some 14-membered macrolide antibiotics have been synthesized from levoglucosan.